Fulgent Genetics Inc (FLGT) — Cash Flow Quality Index

Latest as of September 2022: 15.47x

Fulgent Genetics Inc (FLGT) has a Cash Flow Quality Index of 15.47x as of September 2022. Operating cash flow of $20.78 Million exceeds net income of $1.34 Million, indicating high earnings quality where cash backs reported profits. Explore FLGT cash generation efficiency to assess how effectively this company generates cash.

Cash Flow Quality Index

15.47x
Operating CF / Net Income

Operating Cash Flow

$20.78 Million
USD

Net Income

$1.34 Million
USD

Data as of

Sep 2022
Most recent filing

Fulgent Genetics Inc Cash Flow Quality Index (2020–2022)

Historical Cash Flow Quality Index for Fulgent Genetics Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check FLGT capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Fulgent Genetics Inc (2020–2022)

Year-by-year earnings quality comparison for Fulgent Genetics Inc. For live market cap and the full company financial profile, see Fulgent Genetics Inc market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2022 1.79x $253.52 Million $141.92 Million ▲ +67.9%
2021 1.06x $538.58 Million $506.24 Million ▲ +62.1%
2020 0.66x $140.63 Million $214.31 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.